Myopia prevalence has risen dramatically over the past several decades, particularly in East Asia but increasingly across North America and...
Read moreHealthcare cybersecurity and health system data risk management have moved from technical afterthought to board-level agenda item, driven by ransomware...
Read moreHealth technology assessment is no longer confined to late-stage review after a product reaches market maturity. Payers, integrated delivery networks,...
Read moreClinical guidelines and clinical software operate on fundamentally different update cycles. Guidelines are designed to change slowly. Software is designed...
Read moreHealthcare interoperability is often described as a technical standards problem. The prevailing narrative suggests that once common data standards are...
Read moreAn incisive exploration of how today’s criminal justice apparatus perpetuates harm by conditioning incarcerated individuals into compliance, with profound and...
Read moreThe Invisible Pandemic of Digital Deception In a world where information circulates faster than pathogens, misinformation has emerged as both...
Read moreLong after anesthesia fades, a glioblastoma patient wakes to the same brutal math: median survival just 15 months, five-year survival...
Read moreThe headline sounds apocalyptic, yet the data behind it are mounting. In April 2025, a Cell paper unveiled a new...
Read moreA watch that tracks your heart rate is no longer a novelty—it’s a gateway to your future health. In the...
Read moreIs the key to aging gracefully as simple as a daily vitamin D capsule? The allure is powerful. A recent...
Read moreIt’s not just about what we eat or how we move—it’s also about what our choices say about the planet...
Read moreGlucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy